Quantitative parameters of contrast-enhanced ultrasound effectively promote the prediction of cervical lymph node metastasis in papillary thyroid carcinoma

Papillary thyroid carcinoma (PTC), the most common endocrine tumor, often spreads to cervical lymph nodes metastasis (CLNM). Preoperative diagnosis of CLNM is important when selecting surgical strategies. Therefore, we aimed to explore the effectiveness of quantitative parameters of contrast-enhance...

Full description

Saved in:
Bibliographic Details
Published inDrug Discoveries & Therapeutics Vol. 18; no. 1; pp. 44 - 53
Main Authors Su, Biao, Li, Lisha, Liu, Yingchun, Liu, Hui, Zhan, Jia, Chai, Qiliang, Fang, Liang, Wang, Ling, Chen, Lin
Format Journal Article
LanguageEnglish
Published Japan International Research and Cooperation Association for Bio & Socio-Sciences Advancement 29.02.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Papillary thyroid carcinoma (PTC), the most common endocrine tumor, often spreads to cervical lymph nodes metastasis (CLNM). Preoperative diagnosis of CLNM is important when selecting surgical strategies. Therefore, we aimed to explore the effectiveness of quantitative parameters of contrast-enhanced ultrasound (CEUS) in predicting CLNM in PTC. We retrospectively analyzed 193 patients with PTC undergoing conventional ultrasound (CUS) and CEUS. The CUS features and quantitative parameters of CEUS were evaluated according to PTC size ≤ 10 or > 10 mm, using pathology as the gold standard. For the PTC ≤ 10 mm, microcalcification and multifocality were significantly different between the CLNM (+) and CLNM (-) groups (both P < 0.05). For the PTC > 10 mm, statistical significance was noted between the two groups with respect to the margin, capsule contact, and multifocality (all P < 0.05). For PTC ≤ 10 mm, there was no significant difference between the CLNM (+) and CLNM (-) groups in all quantitative parameters of CEUS (all P > 0.05). However, for PTC > 10 mm, the peak intensity (PI), mean transit time, and slope were significantly associated with CLNM (all P < 0.05). Multivariate analysis showed that PI > 5.8 dB was an independent risk factor for predicting CLNM in patients with PTC > 10 mm (P < 0.05). The area under the curve of PI combined with CUS (0.831) was significantly higher than that of CUS (0.707) or PI (0.703) alone in the receiver operator characteristic curve analysis (P < 0.05). In conclusion, PI has significance in predicting CLNM for PTC > 10 mm; however, it is not helpful for PTC ≤ 10 mm.
AbstractList Papillary thyroid carcinoma (PTC), the most common endocrine tumor, often spreads to cervical lymph nodes metastasis (CLNM). Preoperative diagnosis of CLNM is important when selecting surgical strategies. Therefore, we aimed to explore the effectiveness of quantitative parameters of contrast-enhanced ultrasound (CEUS) in predicting CLNM in PTC. We retrospectively analyzed 193 patients with PTC undergoing conventional ultrasound (CUS) and CEUS. The CUS features and quantitative parameters of CEUS were evaluated according to PTC size ≤ 10 or > 10 mm, using pathology as the gold standard. For the PTC ≤ 10 mm, microcalcification and multifocality were significantly different between the CLNM (+) and CLNM (-) groups (both P < 0.05). For the PTC > 10 mm, statistical significance was noted between the two groups with respect to the margin, capsule contact, and multifocality (all P < 0.05). For PTC ≤ 10 mm, there was no significant difference between the CLNM (+) and CLNM (-) groups in all quantitative parameters of CEUS (all P > 0.05). However, for PTC > 10 mm, the peak intensity (PI), mean transit time, and slope were significantly associated with CLNM (all P < 0.05). Multivariate analysis showed that PI > 5.8 dB was an independent risk factor for predicting CLNM in patients with PTC > 10 mm (P < 0.05). The area under the curve of PI combined with CUS (0.831) was significantly higher than that of CUS (0.707) or PI (0.703) alone in the receiver operator characteristic curve analysis (P < 0.05). In conclusion, PI has significance in predicting CLNM for PTC > 10 mm; however, it is not helpful for PTC ≤ 10 mm.
ArticleNumber 2023.01095
Author Li, Lisha
Zhan, Jia
Chen, Lin
Liu, Yingchun
Su, Biao
Liu, Hui
Chai, Qiliang
Fang, Liang
Wang, Ling
Author_xml – sequence: 1
  fullname: Su, Biao
  organization: Department of Ultrasound, Huadong Hospital, Fudan University, Shanghai, China
– sequence: 2
  fullname: Li, Lisha
  organization: Department of Reproductive Immunology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China
– sequence: 3
  fullname: Liu, Yingchun
  organization: Department of Ultrasound, Huadong Hospital, Fudan University, Shanghai, China
– sequence: 4
  fullname: Liu, Hui
  organization: Department of Ultrasound, Huadong Hospital, Fudan University, Shanghai, China
– sequence: 5
  fullname: Zhan, Jia
  organization: Department of Ultrasound, Huadong Hospital, Fudan University, Shanghai, China
– sequence: 6
  fullname: Chai, Qiliang
  organization: Department of Ultrasound, Huadong Hospital, Fudan University, Shanghai, China
– sequence: 7
  fullname: Fang, Liang
  organization: Department of Ultrasound, Huadong Hospital, Fudan University, Shanghai, China
– sequence: 8
  fullname: Wang, Ling
  organization: Department of Reproductive Immunology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China
– sequence: 9
  fullname: Chen, Lin
  organization: Department of Ultrasound, Huadong Hospital, Fudan University, Shanghai, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38355122$$D View this record in MEDLINE/PubMed
BookMark eNpFUU1P3DAQtSqqQilXjsh_IFtPPp0jgkIrIVWVOPQWTexx1yixI9uLtL-lf7bOLmx9GI9m3nsz9vvMzpx3xNg1iE3TyPKr1mlTirLaCBB984FdgJRQdLL-fXbKKzhnVzG-iHyaWoJsPrHzSlZNA2V5wf7-2qFLNmGyr8QXDDhTohC5N1x5lwLGVJDbolOk-W5aC37nNCdjSK2kac-X4GefiKdtlgikbW54d5Cg8GoVTnzaz8uWO6-J5wFZFKON3Lo8crHThGGf2fvgreYKg7LOz_iFfTQ4Rbp6uy_Z88O357vvxdPPxx93t0-FqkuZCoOAZLQe-w6gq_qmrQWMnQDd912rxlwUgLo1QiiNfY0GTAvQU9WOqh-rS3ZzlF1240x6WIKd8z7D-ydlwOYIUMHHGMicICCG1YghGzGsRgwHIzLh_kh4ye_8Qyc4hmTVRAc4yAHW8J92aqsthoFc9Q91FJhw
Cites_doi 10.1089/thy.2008.0243
10.5858/2006-130-1057-PTCAO
10.1002/dc.20898
10.1055/s-0044-101254
10.3892/etm.2017.5087
10.1097/MD.0000000000014051
10.1097/MD.0000000000013325
10.1016/j.ejrad.2019.108801
10.1177/1758835920942367
10.1155/2013/965212
10.5662/wjm.v12.i5.448
10.2147/CMAR.S169741
10.1007/s00261-023-03804-5
10.2147/CMAR.S265756
10.3389/fendo.2023.1052862
10.3892/mco.2016.1053
10.1371/journal.pone.0090674
10.1089/thy.2015.0020
10.3322/caac.21439
10.1016/j.ultrasmedbio.2016.11.009
10.1016/j.ejso.2017.07.008
10.2147/CMAR.S199921
10.3389/fendo.2021.666315
10.1186/s12885-019-5835-6
10.1097/MD.0000000000002558
10.1097/MD.0000000000008365
10.1038/s41598-018-36171-z
10.1109/TUFFC.2010.1550
10.1002/hed.25941
10.1016/S0039-6060(03)00424-0
10.1016/j.bjorl.2020.05.004
10.1002/jum.15315
10.1016/j.surg.2008.09.003
10.3389/fendo.2022.812475
10.1007/s11547-019-01129-2
10.1002/jcu.23073
10.21037/gs-20-75
10.1016/j.ejso.2016.07.002
10.1089/thy.2009.1608
10.1016/j.canep.2015.04.015
10.7863/jum.2013.32.3.429
10.3233/CH-221545
10.2217/fon-2020-0069
10.1210/jc.2014-3825
10.21037/gs.2020.03.02
10.1530/EC-22-0341
10.1007/s40618-018-0908-y
10.3233/CH-180454
10.1507/endocrj.EJ12-0311
10.7863/jum.2012.31.6.915
10.1177/0300060517708943
ContentType Journal Article
Copyright 2024 International Research and Cooperation Association for Bio & Socio-Sciences Advancement
Copyright_xml – notice: 2024 International Research and Cooperation Association for Bio & Socio-Sciences Advancement
DBID AAYXX
CITATION
NPM
DOI 10.5582/ddt.2023.01095
DatabaseName CrossRef
PubMed
DatabaseTitle CrossRef
PubMed
DatabaseTitleList
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1881-784X
EndPage 53
ExternalDocumentID 38355122
10_5582_ddt_2023_01095
article_ddt_18_1_18_2023_01095_article_char_en
Genre Journal Article
GroupedDBID ---
53G
ABDBF
ADBBV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
DIK
EBD
EMOBN
ESX
F5P
JSF
JSH
KQ8
MK0
OK1
P2P
RJT
RZJ
SV3
TUS
7.U
AAYXX
ACUHS
CITATION
NPM
ID FETCH-LOGICAL-c428t-fa1aefddb971173956401b701d9976cb11701ad6f00cda94af1f6119e36bc9b3
ISSN 1881-7831
IngestDate Mon Jul 21 05:57:13 EDT 2025
Tue Jul 01 01:15:40 EDT 2025
Fri Apr 12 19:05:15 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords quantitative parameter
cervical lymph node metastasis
papillary thyroid carcinoma
contrast-enhanced ultrasound
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c428t-fa1aefddb971173956401b701d9976cb11701ad6f00cda94af1f6119e36bc9b3
OpenAccessLink https://www.jstage.jst.go.jp/article/ddt/18/1/18_2023.01095/_article/-char/en
PMID 38355122
PageCount 10
ParticipantIDs pubmed_primary_38355122
crossref_primary_10_5582_ddt_2023_01095
jstage_primary_article_ddt_18_1_18_2023_01095_article_char_en
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024/02/29
PublicationDateYYYYMMDD 2024-02-29
PublicationDate_xml – month: 02
  year: 2024
  text: 2024/02/29
  day: 29
PublicationDecade 2020
PublicationPlace Japan
PublicationPlace_xml – name: Japan
PublicationTitle Drug Discoveries & Therapeutics
PublicationTitleAlternate DD&T
PublicationYear 2024
Publisher International Research and Cooperation Association for Bio & Socio-Sciences Advancement
Publisher_xml – name: International Research and Cooperation Association for Bio & Socio-Sciences Advancement
References 39. Li QL, Ma T, Wang ZJ, Huang L, Liu W, Chen M, Sang T, Ren XG, Tong J, Cao CL, Dong J, Li J. The value of contrast-enhanced ultrasound for the diagnosis of metastatic cervical lymph nodes of papillary thyroid carcinoma: A systematic review and meta-analysis. J Clin Ultrasound. 2022; 50:60-69.
25. Perrier ND, Brierley JD, Tuttle RM. Differentiated and anaplastic thyroid carcinoma: Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2018; 68:55-63.
5. Baek SK, Jung KY, Kang SM, Kwon SY, Woo JS, Cho SH, Chung EJ. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma. Thyroid. 2010; 20:147-152.
41. Zhan J, Diao X, Chen Y, Wang W, Ding H. Predicting cervical lymph node metastasis in patients with papillary thyroid cancer (PTC) - Why contrast-enhanced ultrasound (CEUS) was performed before thyroidectomy. Clin Hemorheol Microcirc. 2019; 72:61-73.
6. Xu S, Yao J, Zhou W, Chen L, Zhan W. Clinical characteristics and ultrasonographic features for predicting central lymph node metastasis in clinically node‐negative papillary thyroid carcinoma without capsule invasion. Head Neck. 2019; 41:3984-3991.
15. Li J, Liu J, Qian L. Suspicious ultrasound characteristics correlate with multiple factors that predict central lymph node metastasis of papillary thyroid carcinoma: Significant role of HBME-1. Eur J Radiol. 2020; 123:108801.
7. Zhang L, Yang J, Sun Q, Liu Y, Liang F, Liu Z, Chen G, Chen S, Shang Z, Li Y, Li X. Risk factors for lymph node metastasis in papillary thyroid microcarcinoma: older patients with fewer lymph node metastases. Eur J Surg Oncol. 2016; 42:1478-1482.
35. Sidhu P, Cantisani V, Dietrich C, et al. The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (Short Version). Ultraschall Med. 2018; 39:154-180.
8. Machens A, Hauptmann S, Dralle H. Lymph node dissection in the lateral neck for completion in central node-positive papillary thyroid cancer. Surgery. 2009; 145:176-181.
42. Zhan J, Zhang LH, Yu Q, Li CL, Chen Y, Wang WP, Ding H. Prediction of cervical lymph node metastasis with contrast-enhanced ultrasound and association between presence of BRAF(V600E) and extrathyroidal extension in papillary thyroid carcinoma. Ther Adv Med Oncol. 2020; 12:1758835920942367.
31. Chen BD, Zhang Z, Wang KK, Shang MY, Zhao SS, Ding WB, Du R, Yu Z, Xu XM. A multivariable model of BRAFV600E and ultrasonographic features for predicting the risk of central lymph node metastasis in cN0 papillary thyroid microcarcinoma. Cancer Manag Res. 2019; 11:7211-7217.
1. Colonna M, Uhry Z, Guizard AV, Delafosse P, Schvartz C, Belot A, Grosclaude P; FRANCIM network. Recent trends in incidence, geographical distribution, and survival of papillary thyroid cancer in France. Cancer Epidemiol. 2015; 39:511-518.
50. Strouthos C, Lampaskis M, Sboros V, Mcneilly A, Averkiou M. Indicator dilution models for the quantification of microvascular blood flow with bolus administration of ultrasound contrast agents. IEEE Trans Ultrason Ferroelectr Freq Control. 2010; 57:1296-1310.
14. Jin WX, Ye DR, Sun YH, Zhou XF, Wang OC, Zhang XH, Cai YF. Prediction of central lymph node metastasis in papillary thyroid microcarcinoma according to clinicopathologic factors and thyroid nodule sonographic features: a case-control study. Cancer Manag Res. 2018; 10:3237-3243.
16. Chen J, Li XL, Zhang YF, Wang D, Wang Q, Zhao CK, Li MX, Wei Q, Ji G, Xu HX. Ultrasound validation of predictive model for central cervical lymph node metastasis in papillary thyroid cancer on BRAF. Future Oncol. 2020; 16:1607-1618.
30. Guo L, Ma YQ, Yao Y, Wu M, Deng ZH, Zhu FW, Luo YK, Tang J. Role of ultrasonographic features and quantified BRAFV600E mutation in lymph node metastasis in Chinese patients with papillary thyroid carcinoma. Sci Rep. 2019; 9:75.
49. Wei S, Fu N, Yao C, Liu P, Yang B. Two-and three-dimensional contrast-enhanced sonography for assessment of renal tumor vasculature: preliminary observations. J Ultrasound Med. 2013; 32:429-437.
20. Xu Y, Qi X, Zhao X, Ren W, Ding W. Clinical diagnostic value of contrast-enhanced ultrasound and TI-RADS classification for benign and malignant thyroid tumors: One comparative cohort study. Medicine (Baltimore). 2019; 98:e14051.
21. Deng J, Zhou P, Tian S, Zhang L, Li J, Qian Y. Comparison of diagnostic efficacy of contrast-enhanced ultrasound, acoustic radiation force impulse imaging, and their combined use in differentiating focal solid thyroid nodules. PLoS One. 2014; 9:e90674.
4. Sipos JA. Advances in ultrasound for the diagnosis and management of thyroid cancer. Thyroid. 2009; 19:1363-1372.
2. Al-Brahim N, Asa SL. Papillary thyroid carcinoma: An overview. Arch Pathol Lab Med. 2006; 130:1057-1062.
37. Wilsen CB, Patel MK, Douek ML, Masamed R, Dittmar KM, Lu DSK, Raman SS. Contrast-enhanced ultrasound for abdominal image-guided procedures. Abdom Radiol (NY). 2023; 48:1438-1453.
18. Chen M, Zhang K, Xu Y, Zhang S, Cao Y, Sun W. Shear wave elastography and contrast-enhanced ultrasonography in the diagnosis of thyroid malignant nodules. Mol Clin Oncol. 2016; 5:724-730.
38. Yu Y, Shi LL, Zhang HW, Wang Q. Performance of contrast-enhanced ultrasound for lymph node metastasis in papillary thyroid carcinoma: A meta-analysis. Endocr Connect. 2023; 12:e220341.
3. Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: Update on epidemiology and risk factors. J Cancer Epidemiol. 2013; 2013:965212.
12. Zhao WJ, Luo H, Zhou YM, Dai WY, Zhu JQ. Evaluating the effectiveness of prophylactic central neck dissection with total thyroidectomy for cN0 papillary thyroid carcinoma: An updated meta-analysis. Eur J Surg Oncol. 2017; 43:1989-2000.
19. Trimboli P, Castellana M, Virili C, Havre RF, Bini F, Marinozzi F, D'Ambrosio F, Giorgino F, Giovanella L, Prosch H, Grani G, Radzina M, Cantisani V. Performance of contrast-enhanced ultrasound (CEUS) in assessing thyroid nodules: A systematic review and meta-analysis using histological standard of reference. Radiol Med. 2020; 125:406-415.
10. Liu C, Xiao C, Chen J, Li X, Feng Z, Gao Q, Liu Z. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients. BMC Cancer. 2019; 19:622.
48. Tao L, Zhou W, Zhan W, Li W, Wang Y, Fan J. Preoperative prediction of cervical lymph node metastasis in papillary thyroid carcinoma via conventional and contrast-enhanced ultrasound. J Ultrasound Med. 2020; 39:2071-2080.
27. Huang C, Cong S, Liang T, Feng Z, Gan K, Zhou R, Guo Y, Luo S, Liang K, Wang Q. Development and validation of an ultrasound-based nomogram for preoperative prediction of cervical central lymph node metastasis in papillary thyroid carcinoma. Gland Surg. 2020; 9:956-967.
24. Liu W, Cheng R, Su Y, Diao C, Qian J, Zhang J, Ma Y, Fan Y. Risk factors of central lymph node metastasis of papillary thyroid carcinoma: A single-center retrospective analysis of 3273 cases. Medicine (Baltimore). 2017; 96:e8365.
34. Feng JW, Hong LZ, Wang F, Wu WX, Hu J, Liu SY, Jiang Y, Ye J. A nomogram based on clinical and ultrasound characteristics to predict central lymph node metastasis of papillary thyroid carcinoma. Front Endocrinol (Lausanne). 2021; 12:666315.
36. Ma J, Wang Y, Xi X, Tang J, Wang L, Wang L, Wang D, Liang X, Zhang B. Contrast-enhanced ultrasound combined targeted microbubbles for diagnosis of highly aggressive papillary thyroid carcinoma. Front Endocrinol (Lausanne). 2023; 14:1052862.
9. Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016; 26:1-133.
22. Liu Q, Cheng J, Li J, Gao X, Li H. The diagnostic accuracy of contrast-enhanced ultrasound for the differentiation of benign and malignant thyroid nodules: A PRISMA compliant meta-analysis. Medicine (Baltimore). 2018; 97:e13325.
28. Ji WL, Ya HL, Kai L, Bo H, Yue JZ, Hao TW, Tao Y. Clinicopathologic factors and preoperative ultrasonographic characteristics for predicting central lymph node metastasis in papillary thyroid microcarcinoma: A single center retrospective study. Braz J Otorhinolaryngol. 2022; 88:36-45.
40. Fang F, Gong Y, Liao L, Ye F, Zuo Z, Li X, Zhang Q, Tang K, Xu Y, Zhang R, Chen S, Niu C. Value of contrast-enhanced ultrasound for evaluation of cervical lymph node metastasis in papillary thyroid carcinoma. Front Endocrinol (Lausanne). 2022; 13:812475.
44. Perivoliotis K, Samara AA, Koutoukoglou P, Ntellas P, Dadouli K, Sotiriou S, Ioannou M, Tepetes K. Microvessel density in differentiated thyroid carcinoma: A systematic review and meta-analysis. World J Methodol. 2022; 12:448-458.
11. Viola D, Materazzi G, Valerio L, et al. Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: Clinical implications derived from the first prospective randomized controlled single institution study. J Clin Endocrinol Metab. 2015; 100:1316-1324.
46. Mori N, Mugikura S, Takahashi S, Ito K, Takasawa C, Li L, Miyashita M, Kasajima A, Mori Y, Ishida T, Kodama T, Takase K. Quantitative analysis of contrast-enhanced ultrasound imaging in invasive breast cancer: A novel technique to obtain histopathologic information of microvessel density. Ultrasound Med Biol. 2017; 43:607-614.
23. Ito Y, Fukushima M, Higashiyama T, Kihara M, Takamura Y, Kobayashi K, Miya A, Miyauchi A. Tumor size is the strongest predictor of microscopic lymph node metastasis and lymph node recurrence of N0 papillary thyroid carcinoma. Endocr J. 2013; 60:113-117.
26. Yao X, Meng Y, Guo R, Lu G, Jin L, Wang Y, Yang D. Value of ultrasound combined with immunohistochemistry evaluation of central lymph node metastasis for the prognosis of papillary thyroid carcinoma. Cance
44
45
46
47
48
49
50
51
10
11
12
13
14
15
16
17
18
19
1
2
3
4
5
6
7
8
9
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
References_xml – reference: 46. Mori N, Mugikura S, Takahashi S, Ito K, Takasawa C, Li L, Miyashita M, Kasajima A, Mori Y, Ishida T, Kodama T, Takase K. Quantitative analysis of contrast-enhanced ultrasound imaging in invasive breast cancer: A novel technique to obtain histopathologic information of microvessel density. Ultrasound Med Biol. 2017; 43:607-614.
– reference: 21. Deng J, Zhou P, Tian S, Zhang L, Li J, Qian Y. Comparison of diagnostic efficacy of contrast-enhanced ultrasound, acoustic radiation force impulse imaging, and their combined use in differentiating focal solid thyroid nodules. PLoS One. 2014; 9:e90674.
– reference: 3. Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: Update on epidemiology and risk factors. J Cancer Epidemiol. 2013; 2013:965212.
– reference: 22. Liu Q, Cheng J, Li J, Gao X, Li H. The diagnostic accuracy of contrast-enhanced ultrasound for the differentiation of benign and malignant thyroid nodules: A PRISMA compliant meta-analysis. Medicine (Baltimore). 2018; 97:e13325.
– reference: 35. Sidhu P, Cantisani V, Dietrich C, et al. The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (Short Version). Ultraschall Med. 2018; 39:154-180.
– reference: 47. Liu Y, Zhou H, Yang P, Zhou Y, Wu J, Chen C, Ye M, Luo J. Contrast-enhanced ultrasonography features of papillary thyroid carcinoma for predicting cervical lymph node metastasis. Exp Ther Med. 2017; 14:4321-4327.
– reference: 43. Liu Z, Li C. Correlation of lymph node metastasis with contrast-enhanced ultrasound features, microvessel density and microvessel area in patients with papillary thyroid carcinoma. Clin Hemorheol Microcirc. 2022; 82:361-370.
– reference: 31. Chen BD, Zhang Z, Wang KK, Shang MY, Zhao SS, Ding WB, Du R, Yu Z, Xu XM. A multivariable model of BRAFV600E and ultrasonographic features for predicting the risk of central lymph node metastasis in cN0 papillary thyroid microcarcinoma. Cancer Manag Res. 2019; 11:7211-7217.
– reference: 32. Xu JM, Xu HX, Li XL, Bo XW, Xu XH, Zhang YF, Guo LH, Liu LN, Qu S. A risk model for predicting central lymph node metastasis of papillary thyroid microcarcinoma including conventional ultrasound and acoustic radiation force impulse elastography. Medicine (Baltimore). 2016; 95:e2558.
– reference: 20. Xu Y, Qi X, Zhao X, Ren W, Ding W. Clinical diagnostic value of contrast-enhanced ultrasound and TI-RADS classification for benign and malignant thyroid tumors: One comparative cohort study. Medicine (Baltimore). 2019; 98:e14051.
– reference: 15. Li J, Liu J, Qian L. Suspicious ultrasound characteristics correlate with multiple factors that predict central lymph node metastasis of papillary thyroid carcinoma: Significant role of HBME-1. Eur J Radiol. 2020; 123:108801.
– reference: 29. Luo X, Wang J, Xu M, Zou X, Lin Q, Zheng W, Guo Z, Li A, Han F. Risk model and risk stratification to preoperatively predict central lymph node metastasis in papillary thyroid carcinoma. Gland Surg. 2020; 9:300-310.
– reference: 24. Liu W, Cheng R, Su Y, Diao C, Qian J, Zhang J, Ma Y, Fan Y. Risk factors of central lymph node metastasis of papillary thyroid carcinoma: A single-center retrospective analysis of 3273 cases. Medicine (Baltimore). 2017; 96:e8365.
– reference: 9. Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016; 26:1-133.
– reference: 17. Kouvaraki MA, Shapiro SE, Fornage BD, Edeiken-Monro BS, Sherman SI, Vassilopoulou-Sellin R, Lee JE, Evans DB. Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery. 2003; 134:946-954.
– reference: 48. Tao L, Zhou W, Zhan W, Li W, Wang Y, Fan J. Preoperative prediction of cervical lymph node metastasis in papillary thyroid carcinoma via conventional and contrast-enhanced ultrasound. J Ultrasound Med. 2020; 39:2071-2080.
– reference: 4. Sipos JA. Advances in ultrasound for the diagnosis and management of thyroid cancer. Thyroid. 2009; 19:1363-1372.
– reference: 33. Das DK, Sheikh ZA, George SS, Al-Baquer T, Francis IM. Papillary thyroid carcinoma: Evidence for intracytoplasmic formation of precursor substance for calcification and its release from well-preserved neoplastic cells. Diagn Cytopathol. 2008; 36:809-812.
– reference: 14. Jin WX, Ye DR, Sun YH, Zhou XF, Wang OC, Zhang XH, Cai YF. Prediction of central lymph node metastasis in papillary thyroid microcarcinoma according to clinicopathologic factors and thyroid nodule sonographic features: a case-control study. Cancer Manag Res. 2018; 10:3237-3243.
– reference: 2. Al-Brahim N, Asa SL. Papillary thyroid carcinoma: An overview. Arch Pathol Lab Med. 2006; 130:1057-1062.
– reference: 49. Wei S, Fu N, Yao C, Liu P, Yang B. Two-and three-dimensional contrast-enhanced sonography for assessment of renal tumor vasculature: preliminary observations. J Ultrasound Med. 2013; 32:429-437.
– reference: 27. Huang C, Cong S, Liang T, Feng Z, Gan K, Zhou R, Guo Y, Luo S, Liang K, Wang Q. Development and validation of an ultrasound-based nomogram for preoperative prediction of cervical central lymph node metastasis in papillary thyroid carcinoma. Gland Surg. 2020; 9:956-967.
– reference: 7. Zhang L, Yang J, Sun Q, Liu Y, Liang F, Liu Z, Chen G, Chen S, Shang Z, Li Y, Li X. Risk factors for lymph node metastasis in papillary thyroid microcarcinoma: older patients with fewer lymph node metastases. Eur J Surg Oncol. 2016; 42:1478-1482.
– reference: 16. Chen J, Li XL, Zhang YF, Wang D, Wang Q, Zhao CK, Li MX, Wei Q, Ji G, Xu HX. Ultrasound validation of predictive model for central cervical lymph node metastasis in papillary thyroid cancer on BRAF. Future Oncol. 2020; 16:1607-1618.
– reference: 41. Zhan J, Diao X, Chen Y, Wang W, Ding H. Predicting cervical lymph node metastasis in patients with papillary thyroid cancer (PTC) - Why contrast-enhanced ultrasound (CEUS) was performed before thyroidectomy. Clin Hemorheol Microcirc. 2019; 72:61-73.
– reference: 26. Yao X, Meng Y, Guo R, Lu G, Jin L, Wang Y, Yang D. Value of ultrasound combined with immunohistochemistry evaluation of central lymph node metastasis for the prognosis of papillary thyroid carcinoma. Cancer Manag Res. 2020; 12:8787-8799.
– reference: 5. Baek SK, Jung KY, Kang SM, Kwon SY, Woo JS, Cho SH, Chung EJ. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma. Thyroid. 2010; 20:147-152.
– reference: 6. Xu S, Yao J, Zhou W, Chen L, Zhan W. Clinical characteristics and ultrasonographic features for predicting central lymph node metastasis in clinically node‐negative papillary thyroid carcinoma without capsule invasion. Head Neck. 2019; 41:3984-3991.
– reference: 18. Chen M, Zhang K, Xu Y, Zhang S, Cao Y, Sun W. Shear wave elastography and contrast-enhanced ultrasonography in the diagnosis of thyroid malignant nodules. Mol Clin Oncol. 2016; 5:724-730.
– reference: 25. Perrier ND, Brierley JD, Tuttle RM. Differentiated and anaplastic thyroid carcinoma: Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2018; 68:55-63.
– reference: 36. Ma J, Wang Y, Xi X, Tang J, Wang L, Wang L, Wang D, Liang X, Zhang B. Contrast-enhanced ultrasound combined targeted microbubbles for diagnosis of highly aggressive papillary thyroid carcinoma. Front Endocrinol (Lausanne). 2023; 14:1052862.
– reference: 45. Zhan W, Zhou P, Zhou J, Xu S, Chen K. Differences in sonographic features of papillary thyroid carcinoma between neck lymph node metastatic and nonmetastatic groups. J Ultrasound Med. 2012; 31:915-920.
– reference: 13. Zhao C, Jiang W, Gao Y, Niu W, Zhang X, Xin L. Risk factors for lymph node metastasis (LNM) in patients with papillary thyroid microcarcinoma (PTMC): role of preoperative ultrasound. J Int Med Res. 2017; 45:1221-1230.
– reference: 38. Yu Y, Shi LL, Zhang HW, Wang Q. Performance of contrast-enhanced ultrasound for lymph node metastasis in papillary thyroid carcinoma: A meta-analysis. Endocr Connect. 2023; 12:e220341.
– reference: 34. Feng JW, Hong LZ, Wang F, Wu WX, Hu J, Liu SY, Jiang Y, Ye J. A nomogram based on clinical and ultrasound characteristics to predict central lymph node metastasis of papillary thyroid carcinoma. Front Endocrinol (Lausanne). 2021; 12:666315.
– reference: 39. Li QL, Ma T, Wang ZJ, Huang L, Liu W, Chen M, Sang T, Ren XG, Tong J, Cao CL, Dong J, Li J. The value of contrast-enhanced ultrasound for the diagnosis of metastatic cervical lymph nodes of papillary thyroid carcinoma: A systematic review and meta-analysis. J Clin Ultrasound. 2022; 50:60-69.
– reference: 11. Viola D, Materazzi G, Valerio L, et al. Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: Clinical implications derived from the first prospective randomized controlled single institution study. J Clin Endocrinol Metab. 2015; 100:1316-1324.
– reference: 30. Guo L, Ma YQ, Yao Y, Wu M, Deng ZH, Zhu FW, Luo YK, Tang J. Role of ultrasonographic features and quantified BRAFV600E mutation in lymph node metastasis in Chinese patients with papillary thyroid carcinoma. Sci Rep. 2019; 9:75.
– reference: 19. Trimboli P, Castellana M, Virili C, Havre RF, Bini F, Marinozzi F, D'Ambrosio F, Giorgino F, Giovanella L, Prosch H, Grani G, Radzina M, Cantisani V. Performance of contrast-enhanced ultrasound (CEUS) in assessing thyroid nodules: A systematic review and meta-analysis using histological standard of reference. Radiol Med. 2020; 125:406-415.
– reference: 1. Colonna M, Uhry Z, Guizard AV, Delafosse P, Schvartz C, Belot A, Grosclaude P; FRANCIM network. Recent trends in incidence, geographical distribution, and survival of papillary thyroid cancer in France. Cancer Epidemiol. 2015; 39:511-518.
– reference: 23. Ito Y, Fukushima M, Higashiyama T, Kihara M, Takamura Y, Kobayashi K, Miya A, Miyauchi A. Tumor size is the strongest predictor of microscopic lymph node metastasis and lymph node recurrence of N0 papillary thyroid carcinoma. Endocr J. 2013; 60:113-117.
– reference: 12. Zhao WJ, Luo H, Zhou YM, Dai WY, Zhu JQ. Evaluating the effectiveness of prophylactic central neck dissection with total thyroidectomy for cN0 papillary thyroid carcinoma: An updated meta-analysis. Eur J Surg Oncol. 2017; 43:1989-2000.
– reference: 8. Machens A, Hauptmann S, Dralle H. Lymph node dissection in the lateral neck for completion in central node-positive papillary thyroid cancer. Surgery. 2009; 145:176-181.
– reference: 42. Zhan J, Zhang LH, Yu Q, Li CL, Chen Y, Wang WP, Ding H. Prediction of cervical lymph node metastasis with contrast-enhanced ultrasound and association between presence of BRAF(V600E) and extrathyroidal extension in papillary thyroid carcinoma. Ther Adv Med Oncol. 2020; 12:1758835920942367.
– reference: 37. Wilsen CB, Patel MK, Douek ML, Masamed R, Dittmar KM, Lu DSK, Raman SS. Contrast-enhanced ultrasound for abdominal image-guided procedures. Abdom Radiol (NY). 2023; 48:1438-1453.
– reference: 28. Ji WL, Ya HL, Kai L, Bo H, Yue JZ, Hao TW, Tao Y. Clinicopathologic factors and preoperative ultrasonographic characteristics for predicting central lymph node metastasis in papillary thyroid microcarcinoma: A single center retrospective study. Braz J Otorhinolaryngol. 2022; 88:36-45.
– reference: 51. Luo Y, Zhao Y, Chen K, Shen J, Shi J, Lu S, Lei J, Li Z, Luo D. Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma. J Endocrinol Invest. 2019; 42:227-236.
– reference: 10. Liu C, Xiao C, Chen J, Li X, Feng Z, Gao Q, Liu Z. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients. BMC Cancer. 2019; 19:622.
– reference: 44. Perivoliotis K, Samara AA, Koutoukoglou P, Ntellas P, Dadouli K, Sotiriou S, Ioannou M, Tepetes K. Microvessel density in differentiated thyroid carcinoma: A systematic review and meta-analysis. World J Methodol. 2022; 12:448-458.
– reference: 40. Fang F, Gong Y, Liao L, Ye F, Zuo Z, Li X, Zhang Q, Tang K, Xu Y, Zhang R, Chen S, Niu C. Value of contrast-enhanced ultrasound for evaluation of cervical lymph node metastasis in papillary thyroid carcinoma. Front Endocrinol (Lausanne). 2022; 13:812475.
– reference: 50. Strouthos C, Lampaskis M, Sboros V, Mcneilly A, Averkiou M. Indicator dilution models for the quantification of microvascular blood flow with bolus administration of ultrasound contrast agents. IEEE Trans Ultrason Ferroelectr Freq Control. 2010; 57:1296-1310.
– ident: 5
  doi: 10.1089/thy.2008.0243
– ident: 2
  doi: 10.5858/2006-130-1057-PTCAO
– ident: 33
  doi: 10.1002/dc.20898
– ident: 35
  doi: 10.1055/s-0044-101254
– ident: 47
  doi: 10.3892/etm.2017.5087
– ident: 20
  doi: 10.1097/MD.0000000000014051
– ident: 22
  doi: 10.1097/MD.0000000000013325
– ident: 15
  doi: 10.1016/j.ejrad.2019.108801
– ident: 42
  doi: 10.1177/1758835920942367
– ident: 3
  doi: 10.1155/2013/965212
– ident: 44
  doi: 10.5662/wjm.v12.i5.448
– ident: 14
  doi: 10.2147/CMAR.S169741
– ident: 37
  doi: 10.1007/s00261-023-03804-5
– ident: 26
  doi: 10.2147/CMAR.S265756
– ident: 36
  doi: 10.3389/fendo.2023.1052862
– ident: 18
  doi: 10.3892/mco.2016.1053
– ident: 21
  doi: 10.1371/journal.pone.0090674
– ident: 9
  doi: 10.1089/thy.2015.0020
– ident: 25
  doi: 10.3322/caac.21439
– ident: 46
  doi: 10.1016/j.ultrasmedbio.2016.11.009
– ident: 12
  doi: 10.1016/j.ejso.2017.07.008
– ident: 31
  doi: 10.2147/CMAR.S199921
– ident: 34
  doi: 10.3389/fendo.2021.666315
– ident: 10
  doi: 10.1186/s12885-019-5835-6
– ident: 32
  doi: 10.1097/MD.0000000000002558
– ident: 24
  doi: 10.1097/MD.0000000000008365
– ident: 30
  doi: 10.1038/s41598-018-36171-z
– ident: 50
  doi: 10.1109/TUFFC.2010.1550
– ident: 6
  doi: 10.1002/hed.25941
– ident: 17
  doi: 10.1016/S0039-6060(03)00424-0
– ident: 28
  doi: 10.1016/j.bjorl.2020.05.004
– ident: 48
  doi: 10.1002/jum.15315
– ident: 8
  doi: 10.1016/j.surg.2008.09.003
– ident: 40
  doi: 10.3389/fendo.2022.812475
– ident: 19
  doi: 10.1007/s11547-019-01129-2
– ident: 39
  doi: 10.1002/jcu.23073
– ident: 27
  doi: 10.21037/gs-20-75
– ident: 7
  doi: 10.1016/j.ejso.2016.07.002
– ident: 4
  doi: 10.1089/thy.2009.1608
– ident: 1
  doi: 10.1016/j.canep.2015.04.015
– ident: 49
  doi: 10.7863/jum.2013.32.3.429
– ident: 43
  doi: 10.3233/CH-221545
– ident: 16
  doi: 10.2217/fon-2020-0069
– ident: 11
  doi: 10.1210/jc.2014-3825
– ident: 29
  doi: 10.21037/gs.2020.03.02
– ident: 38
  doi: 10.1530/EC-22-0341
– ident: 51
  doi: 10.1007/s40618-018-0908-y
– ident: 41
  doi: 10.3233/CH-180454
– ident: 23
  doi: 10.1507/endocrj.EJ12-0311
– ident: 45
  doi: 10.7863/jum.2012.31.6.915
– ident: 13
  doi: 10.1177/0300060517708943
SSID ssj0000548185
Score 2.286321
Snippet Papillary thyroid carcinoma (PTC), the most common endocrine tumor, often spreads to cervical lymph nodes metastasis (CLNM). Preoperative diagnosis of CLNM is...
SourceID pubmed
crossref
jstage
SourceType Index Database
Publisher
StartPage 44
SubjectTerms cervical lymph node metastasis
contrast-enhanced ultrasound
papillary thyroid carcinoma
quantitative parameter
Title Quantitative parameters of contrast-enhanced ultrasound effectively promote the prediction of cervical lymph node metastasis in papillary thyroid carcinoma
URI https://www.jstage.jst.go.jp/article/ddt/18/1/18_2023.01095/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/38355122
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Drug Discoveries & Therapeutics, 2024/02/29, Vol.18(1), pp.44-53
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9MwGLa6jQMXxDfdYPIBjcOWESdpPg4cNsZUIW0qokjjFMWJvQaNZOqSQ_kr_Bb-G-9ru07a7TC4RJVrW6mep--H3w8T8nbEpccjr3A4eD9OkOeekxVh4ESguhJXuolMsN757Dwcfws-X4wuBoM_vayltuGH-a8760r-B1UYA1yxSvYfkLWbwgB8BnzhCQjD814Yf2mzShWJYfoPNvH-icktNzpVHE9tbxpHVDMd5G-vcABvUTJJHLAIjzZUPp4wJVMYtlnakLkSIwDh1QIg369qTHYVDWyaYRcT1ZT1Gi8tmoMFO1vM67LARtd5WdVG2Buj92TeXmIkKMd00VKd84b7vcIva9Z_bRXdyqy2eUK6eBuviO6G1KzvoHPzWVutDY_bsn-Q4QWqMDzpyd44Zk4UG6Ug-mM6ifO2wLbE1NJXd5I0elz3IF7XEKNRjB1niwLzaD3_ECODo04XLuP_ayrSJi6Cy4Q7pLA-xfWpWr9BtjzwUkDMbh0dnxyf2kM-sIfRIEKnf_njdONQ3OT96kusGEYPfgCW2PRhxddRNs_0MXlknBV6pJn3hAxE9ZTsTXS388UBnfYwPKB7dNL1QV88I7_79KQdPWkt6S160o6etEdPauhJgS60o6fawtCTKnpSpCft6EnLilp6UkNPaun5nExPP00_jh1zF4iTg4PcODJjmZBFwZOIMQwuh4HLeOSyIgGDOud4gRIDKSNdNy-yJMgkkyFjifBDnifcf0E2q7oSrwiNCz8SkceFG_NAhjwOfVcKj8dBxpNMiCF5t8QhvdYdX9K7YR-SDxomO89IAjWPxSnDRzfffo0FlSC_huSlRteu98EfAgvc2773O-yQh91_6TXZbOateANmcsN3DRl3ycb55OwvkaHJvQ
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Quantitative+parameters+of+contrast-enhanced+ultrasound+effectively+promote+the+prediction+of+cervical+lymph+node+metastasis+in+papillary+thyroid+carcinoma&rft.jtitle=Drug+discoveries+%26+therapeutics&rft.au=Su%2C+Biao&rft.au=Li%2C+Lisha&rft.au=Liu%2C+Yingchun&rft.au=Liu%2C+Hui&rft.date=2024-02-29&rft.issn=1881-7831&rft.eissn=1881-784X&rft.volume=18&rft.issue=1&rft.spage=44&rft.epage=53&rft_id=info:doi/10.5582%2Fddt.2023.01095&rft.externalDBID=n%2Fa&rft.externalDocID=10_5582_ddt_2023_01095
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1881-7831&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1881-7831&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1881-7831&client=summon